Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

M1 Kliniken AG

M12
Current price
17.9 EUR +0.15 EUR (+0.85%)
Last closed 17.85 EUR
ISIN DE000A0STSQ8
Sector Healthcare
Industry Medical Distribution
Exchange Frankfurt Exchange
Capitalization 334 757 566 EUR
Yield for 12 month +108.43 %
1Y
3Y
5Y
10Y
15Y
M12
21.11.2021 - 28.11.2021

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas comprising oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG. Address: GrUenauer Strasse 5, Berlin, Germany, 12557

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

24.69 EUR

P/E ratio

19.4444

Dividend Yield

2.83 %

Current Year

+316 351 316 EUR

Last Year

+285 337 471 EUR

Current Quarter

+167 768 412 EUR

Last Quarter

+165 533 373 EUR

Current Year

+26 648 540 EUR

Last Year

+21 727 081 EUR

Current Quarter

+22 706 673 EUR

Last Quarter

+14 622 358 EUR

Key Figures M12

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 24 960 991 EUR
Operating Margin TTM 8.63 %
PE Ratio 19.4444
Return On Assets TTM 6.72 %
PEG Ratio
Return On Equity TTM 12.8 %
Wall Street Target Price 24.69 EUR
Revenue TTM 333 320 404 EUR
Book Value 5.89 EUR
Revenue Per Share TTM
Dividend Share 0.5 EUR
Quarterly Revenue Growth YOY 11.2 %
Dividend Yield 2.83 %
Gross Profit TTM 31 238 057 EUR
Earnings per share 0.9 EUR
Diluted Eps TTM 0.9 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 211.8 %
Profit Margin 5.03 %

Dividend Analytics M12

Dividend growth over 5 years

Continuous growth

1 year

Payout Ratio 5 years average

54 %

Dividend History M12

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.5
Ex Dividend Date 18.07.2024
Forward Annual Dividend Yield 2.86 %
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation M12

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 19.4444
Forward PE
Enterprise Value Revenue 0.9653
Price Sales TTM 1.0043
Enterprise Value EBITDA 10.242
Price Book MRQ 3.0605

Financials M12

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators M12

For 52 weeks

7.99 EUR 21.76 EUR
50 Day MA 16.36 EUR
Shares Short Prior Month
200 Day MA 15.44 EUR
Short Ratio
Shares Short
Short Percent